Recruiting Studies
Advanced SearchData: ClinicalTrials.gov · Source of record for eligibility and locations
Top Cities for Mesothelioma Clinical Trials
Mesothelioma clinical trials are recruiting across 50 cities. Here are the cities with the most active studies:
Mesothelioma Trial Phases
14 research organizations are sponsoring mesothelioma trials.
About Mesothelioma
Mesothelioma is a rare cancer that develops in the thin tissue lining the lungs, abdomen, or heart, primarily caused by asbestos exposure. Most cases are pleural mesothelioma affecting the lung lining. Treatment includes surgery, chemotherapy, radiation, and immunotherapy.
Clinical trials are advancing new treatments for mesothelioma. Currently, 26 studies are recruiting a combined 6,731 participants across the United States. Research is being conducted by 14 organizations including National Cancer Institute (NCI), University of Chicago, Bristol-Myers Squibb and 11 others.
2026 Mesothelioma Research Landscape
As of July 2026, the mesothelioma clinical trial landscape includes 26 actively recruiting studies across 50 cities in the United States. These studies are collectively seeking 6,731 participants, with an average enrollment target of 259 per study.
The research spans multiple phases of development: 11 studies are in PHASE1, 10 studies are in PHASE2, 3 studies are in NA. Early-phase studies suggest new therapeutic approaches are being explored for mesothelioma.
Research is being led by 14 different organizations, including National Cancer Institute (NCI), University of Chicago, Bristol-Myers Squibb, Dana-Farber Cancer Institute, Orion Corporation, Orion Pharma, and 9 others. The large number of sponsors reflects significant research interest and investment in mesothelioma treatment advancement.
Geographically, mesothelioma trials are most concentrated in Chicago, Illinois (7 trials); Bethesda, Maryland (6 trials); Houston, Texas (5 trials); Basking Ridge, New Jersey (4 trials); Middletown, New Jersey (4 trials) and 7 other cities.
Featured Mesothelioma Studies
Highlighted recruiting studies for mesothelioma, selected by enrollment size and research scope.
Evaluation of Cell Changes in Blood and Tissue in Cancers of the Lung, Esophagus and Lung Lining
Background: * Chromatin is is the structural building block of a chromosome. It is found inside the nucleus of the cell and consists of a complex of DNA and protein. * Cancers of the lung, pleura (lung lining) and esophagus show profound changes in chromatin structure that may affect the course of disease in patients. * A better understanding of these diseases and the genetic changes associated w...
Tissue Procurement for Gastric Cancer, Gastrointestinal Stromal Tumors (GIST), Esophageal Cancer, Pancreas Cancer, Hepatocellular Cancer, Biliary Cancer, Neuroendocrine, Peritoneal Mesothelioma, Anal Cancer and Colorectal Cancer in Patients Undergoing Surgery or Biopsy
The purpose of this study is to collect and store normal and malignant tissue from patients with gastric cancer, GIST, esophageal cancer, pancreas cancer, hepatocellular cancer, biliary cancer, neuroendocrine, peritoneal mesothelioma, anal cancer and colorectal cancer, an estimated 50 to 100 of each tumor type. To collect and store blood samples from patients with gastric cancer, GIST, esophageal ...
Tissue Procurement and Natural History Study of Patients With Malignant Mesothelioma
Background: * Malignant mesothelioma is a malignancy arising from the mesothelial cells of the pleura, peritoneum, pericardium, or tunica vaginalis. * Mesothelioma accounts for 0.10% of deaths annually in the United States. Malignant pleural mesothelioma is the most common of these, comprising of 80% of the cases with an annual incidence of about 2,500 in the United States. * The median survival ...
Frequently Asked Questions About Mesothelioma Clinical Trials
Are there mesothelioma clinical trials near me?
Yes, there are 26 mesothelioma clinical trials currently recruiting across 50+ cities in the United States, including Chicago, Illinois; Bethesda, Maryland; Houston, Texas. Browse the studies above to find one at a location convenient for you.
How do I join a mesothelioma clinical trial?
To join a mesothelioma clinical trial: 1) Browse the available studies on this page, 2) Click on a study that interests you, 3) Check the study locations to find a site near you, 4) Review the eligibility criteria, and 5) Contact the study site or complete the eligibility form. The process is free and you can withdraw at any time.
Are mesothelioma clinical trials free?
Yes, participation in mesothelioma clinical trials is free. Study-related treatments, medical tests, and doctor visits are provided at no cost to participants. Many studies also offer compensation for your time and travel expenses.
What types of mesothelioma treatments are being studied?
Current mesothelioma clinical trials are testing a range of approaches across PHASE1 (11 studies), PHASE2 (10 studies), NA (3 studies). These include new drugs, combination therapies, medical devices, and other interventions sponsored by 14 research organizations.
Is it safe to participate in mesothelioma clinical trials?
Clinical trials are carefully regulated by the FDA and institutional review boards (IRBs). All trials must follow strict safety protocols, and participants receive close medical monitoring throughout the study. You can withdraw from a trial at any time without penalty.
Data updated July 17, 2026 from ClinicalTrials.gov
About This Data
Data: ClinicalTrials.gov · Source of record for eligibility and locations
Clinical trial information on this page is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health (NIH) and National Library of Medicine (NLM). Study data is refreshed every hour to ensure accuracy.
Medical Disclaimer: The information provided on this page is for informational purposes only and does not constitute medical advice. Always consult with a qualified healthcare provider before making decisions about clinical trial participation or changes to your treatment plan.
Page reviewed by the HelloStudys Research Team · Last updated July 17, 2026 · Data from ClinicalTrials.gov